Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Marijn Verhoef joins workshop on expanding measurement of patient reach

The Bill & Melinda Gates Foundation is hosting a workshop titled ‘Towards Harmonizing Access and Impact Measures’, which will focus on broadening the scope of how pharmaceutical companies measure the number of patients reached through access efforts. Marijn Verhoef, Director of Operations and Government Engagement at the Access to Medicine Foundation, will attend and share insights from the Foundation’s work on companies' patient reach approaches.

Date

16 October 2024

Location

Berlin, Germany

In October 2024, The Bill & Melinda Gates Foundation will host the second in a series of three workshops aimed at standardising access and impact measurement standards among biopharmaceutical organisations. This initiative is part of a broader project to map existing Access and Impact reporting frameworks within the biopharmaceutical sector, with the goal of increasing alignment across stakeholder perspectives by promoting a core set of concepts and metrics to reduce fragmentation and minimise redundancy. 

Attendees will include representatives from companies, regulators, investors, governments, academia, multilateral organisations and standard setters in capital markets. Building on the outcomes of the first workshop, which focused on exchanging perspectives and current approaches to access programme measurement, the key priorities for this more technically focused session are: 

  • Reviewing and discussing current frameworks for capturing the impact of company access strategies on people, and brainstorming potential revisions to impact materiality disclosure standards. 

  • Reviewing and discussing current frameworks for capturing the effect of access that contributes to social goals on company business performance, along with exploring potential revisions to financial materiality disclosure standards. 

  • Reviewing the landscape of existing data sources and discussing strategies for addressing key gaps. 

During the workshop, Marijn will participate in a panel discussion 'Impact Materiality Reporting' where he will be sharing findings and recommendations from the Foundation’s latest report on how companies measure and report the number of patients reached with their essential products. He will also discuss research from the Index programme, which is conducting more analysis on patient reach for the upcoming Access to Medicine Index, set to launch in November. 

About the Bill & Melinda Gates Foundation  

The Bill & Melinda Gates Foundation is a nonprofit organisation that aims to fight poverty, disease and inequity around the world through its work. It is also a funder of the Access to Medicine Foundation. For more information, click here. 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Resource Centre

Explore our research reports and publications
Featured Research

The Methodology for the 2024 Access to Medicine Index

10 October 2023
Event

Foundation and WEF’s joint event on equitable access: Meeting Report

18 June 2024
Media

How investors can bolster global health equity while generating long-term value

12 February 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved